← FDA Warning Letters
BioLab Sciences, Inc.
FDA Warning Letter · 2022-09-20 · Office of Biological Products Operations – Division 2
Letter
- Company
- BioLab Sciences, Inc.
- Posted Date
- 2022-09-20
- Letter Issue Date
- 2022-08-23
- Issuing Office
- Office of Biological Products Operations – Division 2
Subject
Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)
Source
- Authoritative
- FDA Warning Letters
- Machine
- JSON-LD · Markdown